Last reviewed · How we verify
NCT06677073
Effects of FATmax Exercise and HIIT on Fat Loss in Overweight Young Women
NA trial testing High-intensity interval training in Overweight in 20 participants. Completed in 30 December 2021.
30 September 2021
Quick facts
| Lead sponsor | Beijing Sport University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 20 |
| Start date | 15 April 2021 |
| Primary completion | 30 September 2021 |
| Estimated completion | 30 December 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- High-intensity interval training
- Maximal fat oxidation exercise
Conditions studied
- Overweight — all drugs for Overweight →
Sponsor
Beijing Sport University
Who can join
Adults 18 to 30, female only, with Overweight. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigated the effects of two exercise modalities: high-intensity interval training (HIIT) and maximal fat oxidation (FATmax) exercise on fat loss in overweight young women. Participants were randomly assigned to either the HIIT or FATmax group, underwent an 8-week supervised exercise intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06677073
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High-intensity interval training
Trials testing the same drug.
- NCT07397702 — Effects of HIIT and MICT Training on Cardiorespiratory Fitness, Testosterone/Cortisol Ratio, and Mental Health in Young · NA · not yet recruiting
- NCT07132385 — Feasibility of Different Types of Exercise Training in Perimenopausal Females · NA · recruiting
- NCT06474832 — High Intensity Interval Training in Chronic Stroke · NA · recruiting
- NCT07215533 — Effects of HIIT vs. TRE on Type 2 Diabetes Risk · NA · recruiting
- NCT06374732 — The Benefits of a High-intensity Interval Training Intervention Delivered in a School Setting Among Adolescents · NA · completed
Other recruiting trials for Overweight
Currently open trials in the same condition.
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07472881 — Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women · NA · recruiting
- NCT07465965 — A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults · Phase 1 · recruiting
- NCT07407348 — A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the · Phase 1 · recruiting
- NCT07400653 — A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) · Phase 3 · recruiting
Other Beijing Sport University trials
Trials by the same sponsor.
- NCT07591194 — The Effects of Immersive Virtual Reality-Based Exergaming Combined With Transcranial Direct Current Stimulation on Execu · NA · not yet recruiting
- NCT07360821 — Investigation of Autonomic Stress Response Patterns in College Students With Varying Physical Activity Levels · not yet recruiting
- NCT07496944 — Effects of Blood Flow Restriction and Small-Sided Games on Soccer Passing and Dribbling Stability Under Fatigue · NA · completed
- NCT07509970 — Effects of Astaxanthin Supplementation on Soccer Performance Under Fatigue · NA · completed
- NCT07264907 — Tai Chi Improves Sleep Quality in Mild to Moderate Chronic Insomnia Patients · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06677073 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beijing Sport University
- Last refreshed: 6 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06677073.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing